Lead Burden and ADHD Symptoms in Children and Adolescents: A Meta-Analysis

2012 ◽  
Author(s):  
James K. Goodlad ◽  
David K. Marcus ◽  
Jessica J. Fulton
2010 ◽  
Vol 15 (8) ◽  
pp. 674-683 ◽  
Author(s):  
Philip L. Hazell ◽  
Michael R. Kohn ◽  
Ruth Dickson ◽  
Richard J. Walton ◽  
Renee E. Granger ◽  
...  

Objective: Previous studies comparing atomoxetine and methylphenidate to treat ADHD symptoms have been equivocal. This noninferiority meta-analysis compared core ADHD symptom response between atomoxetine and methylphenidate in children and adolescents. Method: Selection criteria included randomized, controlled design; duration 6 weeks; and assessment of ADHD Rating Scale–IV–Parent Version: Investigator Administered and Scored (ADHDRS) scores. Six-week response rates, defined as ≥40% reduction in ADHDRS total score, were compared using a noninferiority margin of −15%. Results: Seven studies met inclusion criteria ( N = 1,368). After 6 weeks, 53.6% (95% confidence interval [CI] 48.6%-58.4%) of atomoxetine-treated patients ( n = 811) had responded compared with 54.4% (47.6%-61.1%) for methylphenidate ( n = 557), with atomoxetine demonstrating noninferiority to methylphenidate (absolute difference −0.9%, 95% CI −9.2%-7.5%). Conclusion: After 6 weeks of treatment atomoxetine and methylphenidate had comparable efficacy in reducing core ADHD symptoms in children and adolescents.


2021 ◽  
Author(s):  
Walbert de Andrade Vieira ◽  
Vanessa Gallego Arias Pecorari ◽  
Paulo Henrique Gabriel ◽  
Júlio Vargas‐Neto ◽  
Eduardo César Almada Santos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document